FFVAX — Fidelity Advisor Freedom 2015 Fund, Class A

Data updated: 2026-08-24

FFVAX — Fidelity Advisor Freedom 2015 Fund, Class A. 0.74% expense ratio · 5.75% max sales load · since 2003. Holdings, fees, performance and SEC filings.

FFVAX Fund Overview

FFVAX — Fidelity Advisor Freedom 2015 Fund, Class A is a US mutual fund managed by Fidelity Management & Research Company LLC, categorised as Target-Date. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

  • Type: US mutual fund
  • Adviser: Fidelity Management & Research Company LLC
  • Trust: Fidelity Aberdeen Street Trust
  • Category: Target-Date
  • Minimum investment: no minimum
  • Additional investment: no minimum
  • Inception date: November 6, 2003
  • Assets under management: $414.33M
  • 1-year return: 11.0%
  • Ticker: FFVAX
  • SEC CIK: 0000880195
  • SEC series ID: S000004878
  • Share class ID: C000013204
  • FIGI: BBG000C466L4
  • LEI: 28MU360UQYMI212DNC93

About FFVAX

Fidelity Advisor Freedom 2015 Fund (FFVAX) seeks high total return by investing primarily in a mix of Fidelity U.S. equity, international equity, bond and short-term funds. It follows a neutral asset allocation glide path that gradually shifts toward the allocation of the Fidelity Advisor Freedom Retirement Fund, and it may actively adjust asset class exposures by up to 10% to reflect the Adviser's outlook. Its Class A shares, launched November 6, 2003, cost 0.74% a year and returned 11.0% in the 12 months to June 30, 2026, based on monthly returns reported to the SEC on Form N-PORT, with 5.9% volatility. They carry a maximum 5.75% front-end sales charge.

FFVAX Holdings

Top 10 holdings of Fidelity Advisor Freedom 2015 Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.

Holding% of net assets
Fidelity Salem Street Trust28.93%
Fidelity Salem Street Trust12.01%
Fidelity Investment Trust5.70%
Fidelity School Street Trust4.61%
Fidelity Hastings Street Trust4.45%
Fidelity Salem Street Trust4.01%
Fidelity Salem Street Trust3.79%
Fidelity Investment Trust3.16%
Fidelity Advisor Series I3.16%
Fidelity Investment Trust3.07%

View all FFVAX holdings

FFVAX Portfolio Allocation

Asset-class allocation of Fidelity Advisor Freedom 2015 Fund by percentage of net assets, from the latest SEC N-PORT filing.

Asset classAllocation
Equity99.6%
Fixed Income0.3%
Cash & Equivalents0.1%
Real Estate0.1%

FFVAX Performance

Total returns for FFVAX through June 2026, from SEC filings.

PeriodTotal return
YTD5.71%
1 year11.03%
3 years (annualised)9.61%
5 years (annualised)3.81%

FFVAX Risk Information

Risk metrics for FFVAX, derived from monthly returns in SEC filings.

  • 1-year volatility (annualised): 5.89%

FFVAX Costs and Fees

FFVAX costs about $74 per $10,000 invested per year in fund expenses.

  • Net expense ratio: 0.74%
  • Gross expense ratio: 0.74%
  • Portfolio turnover: 18%
  • Brokerage commissions: 0.12 bps of average net assets (SEC N-CEN)

FFVAX Cashflows

Over the 12 months to 2026-06, Fidelity Advisor Freedom 2015 Fund had net outflows of $39.23M, from monthly SEC N-PORT filings.

MonthNet flow
2026-06−$4.97M
2026-05$2.63M
2026-04−$3.19M
2026-03−$4.77M
2026-02−$3.15M
2026-01−$5.54M

FFVAX Debt Constituents

Largest debt holdings of Fidelity Advisor Freedom 2015 Fund by percentage of net assets, from the latest SEC N-PORT filing.

Debt holding% of net assets
Ust Bills0.15%
Ust Bills0.07%
Ust Bills0.05%

FFVAX Prospectus and SEC Filings

Official Fidelity Advisor Freedom 2015 Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

FFVAX Service Providers

Firms that manage, distribute, hold, administer and audit Fidelity Advisor Freedom 2015 Fund, as reported on SEC Form N-CEN, fiscal year ending March 31, 2026.

  • Adviser: Fidelity Management & Research Company LLC
  • Distributor: Fidelity Distributors Company LLC
  • Custodian: Bank of New York Mellon
  • Transfer agent: Fidelity Investments Institutional Operations Company LLC
  • Administrator: Fidelity Service Company
  • Auditors: Deloitte & Touche LLP and PricewaterhouseCoopers LLP

Related Funds

Other Target-Date funds tracked on ABC INVEST:

FFVAX: Frequently Asked Questions

What is the expense ratio of Fidelity Advisor Freedom 2015 Fund (FFVAX)?

FFVAX has a net expense ratio of 0.74%, about $74 a year for every $10,000 invested. FFVAX fees and costs

Does FFVAX charge a sales load?

Yes. FFVAX carries a front-end sales load of up to 5.75% on purchases.

What is the minimum investment for FFVAX?

FFVAX has no minimum initial investment, and there is no minimum for additional purchases. The fund may waive or reduce these minimums. Source: the fund's prospectus (May 2026).

What are FFVAX's top holdings?

As of June 30, 2026, FFVAX held 44 positions. The largest are Fidelity Salem Street Trust (28.93%), Fidelity Salem Street Trust (12.01%), Fidelity Investment Trust (5.70%), Fidelity School Street Trust (4.61%) and Fidelity Hastings Street Trust (4.45%). All FFVAX holdings

Can I download the full list of FFVAX holdings?

Yes. The complete FFVAX holdings list as of June 30, 2026 can be downloaded as a CSV file from the Holdings page: holding, ticker, FIGI, sector, country, asset type, shares, value and share of net assets, from the fund's SEC N-PORT filing. Download FFVAX holdings (CSV)

How has Fidelity Advisor Freedom 2015 Fund performed?

FFVAX returned +11.0% over the 12 months to June 2026, +9.6% a year over 3 years and +3.8% a year over 5 years. FFVAX performance and risk

How large is FFVAX?

FFVAX manages $414.33M (SEC N-PORT, June 2026). Investors withdrew a net $39.23M over the past 12 months.

Who manages FFVAX and when did it launch?

FFVAX is managed by Fidelity Management & Research Company LLC. It is a series of Fidelity Aberdeen Street Trust. It launched on November 6, 2003.

How does FFVAX compare with similar Target-Date funds?

Among 325 Target-Date funds with $100M+ in assets, FFVAX ranks #323 of 325 on net expense ratio (0.74%) and #253 of 325 by assets. The largest is Vanguard Target Retirement 2035 Fund (VTTHX). Compare FFVAX with VTTHX

Where can I find FFVAX's prospectus and SEC filings?

FFVAX's latest prospectus (485BPOS) was filed May 26, 2026 and its latest N-PORT holdings report was filed August 24, 2026. All 63 filings are linked on ABC INVEST and on SEC EDGAR (series S000004878). FFVAX SEC filings

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, and annual data from Form N-CEN.

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.